This week, Beyond Biotech examined the evolving landscape of neurodegenerative disease treatment through a conversation with Gain Therapeutics about their first-in-class approach to Parkinson's disease. The episode highlighted how novel mechanisms of action—in this case, protein misfolding correction rather than traditional dopamine replacement—are reshaping what's possible in diseases long considered difficult to modify.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top beyond biotech podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.
Other Weeks
This Week in Beyond Biotech (Sep 7 - Sep 13, 2026)
1 episode · Sep 7 – Sep 13
This Week in Beyond Biotech (Aug 31 - Sep 6, 2026)
1 episode · Aug 31 – Sep 6
This Week in Beyond Biotech (Aug 24 - Aug 30, 2026)
1 episode · Aug 24 – Aug 30
This Week in Beyond Biotech (Aug 17 - Aug 23, 2026)
1 episode · Aug 17 – Aug 23
This Week in Beyond Biotech (Aug 10 - Aug 16, 2026)
1 episode · Aug 10 – Aug 16
This Week in Beyond Biotech (Aug 3 - Aug 9, 2026)
1 episode · Aug 3 – Aug 9
This Week in Beyond Biotech (Jul 20 - Jul 26, 2026)
1 episode · Jul 20 – Jul 26
This Week in Beyond Biotech (Jul 13 - Jul 19, 2026)
1 episode · Jul 13 – Jul 19
This Week in Beyond Biotech (Jul 6 - Jul 12, 2026)
1 episode · Jul 6 – Jul 12
This Week in Beyond Biotech (Jun 29 - Jul 5, 2026)
1 episode · Jun 29 – Jul 5
This Week in Beyond Biotech (Jun 22 - Jun 28, 2026)
1 episode · Jun 22 – Jun 28